West Ward Columbus Inc

General

Total Cases1

Active Cases--

Patents--

CourtsD. Delaware

TypeOperating Company

Elite Ratings

--

--

--

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
08/16/23	Janssen Pharma Inc v. Hikma Pharma USA Inc 1:23-CV-00595 ( D. DE )	NOTICE of Voluntary Dismissal by Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. (Tigan, Jeremy) (Entered: 08/16/2023)
08/16/23	Janssen Pharma Inc v. Hikma Pharma USA Inc 1:23-CV-00595 ( D. DE )	Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,869,844 B2; 11,173,134 B2; 11,311,500 B2; 11,446,260 B2. (Attachments: # 1 Notice of Voluntary Dismissal)(kmd) (Entered: 08/16/2023)
08/16/23	Janssen Pharma Inc v. Hikma Pharma USA Inc 1:23-CV-00595 ( D. DE )	CASE CLOSED per 9 Notice of Voluntary Dismissal. (kmd) (Entered: 08/16/2023)
06/08/23	Janssen Pharma Inc v. Hikma Pharma USA Inc 1:23-CV-00595 ( D. DE )	STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) (Entered: 06/08/2023)
06/07/23	Janssen Pharma Inc v. Hikma Pharma USA Inc 1:23-CV-00595 ( D. DE )	Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:23-cv-00595-CFC, 1:23-cv-00597-CFC (rjb) (Entered: 06/07/2023)
06/06/23	Janssen Pharma Inc v. Hikma Pharma USA Inc 1:23-CV-00595 ( D. DE )	STATEMENT re 1 Complaint, -- Amended Civil Cover Sheet -- by Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc.. (Blumenfeld, Jack) (Entered: 06/06/2023)
06/01/23	Janssen Pharma Inc v. Hikma Pharma USA Inc 1:23-CV-00595 ( D. DE )	Summons Issued as to Hikma Pharmaceuticals PLC on 5/31/2023; Hikma Pharmaceuticals USA Inc. on 5/31/2023; West-Ward Columbus Inc. on 5/31/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued) (vfm) (Entered: 06/01/2023)
06/01/23	Janssen Pharma Inc v. Hikma Pharma USA Inc 1:23-CV-00595 ( D. DE )	Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc.. (vfm) (Entered: 06/01/2023)
06/01/23	Janssen Pharma Inc v. Hikma Pharma USA Inc 1:23-CV-00595 ( D. DE )	Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,869,844 B2 ;11,173,134 B2 ;11,311,500 B2 ;11,446,260 B2. (vfm) (Entered: 06/01/2023)
06/01/23	Janssen Pharma Inc v. Hikma Pharma USA Inc 1:23-CV-00595 ( D. DE )	Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 04/19/2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 9/5/2026. (vfm) (Entered: 06/01/2023)